MECR: Mitochondrial Enoyl-CoA Reductase

A key enzyme in mitochondrial fatty acid synthesis and a gene associated with neurodegenerative disorders

Gene Information Card

Symbol MECR
Full Name mitochondrial trans-2-enoyl-CoA reductase
Gene Type protein-coding
Chromosomal Location 1p35.3
NCBI Gene ID 51102 ncbi.nlm.nih.gov/gene/51102
Ensembl ID ENSG00000116353
UniProt ID Q9BV79
OMIM ID 608205
HGNC ID 19691
Aliases NRBF1, MEPAS, CGI-63

Description

MECR encodes mitochondrial trans-2-enoyl-CoA reductase, a nuclear-encoded enzyme that catalyzes the last step of mitochondrial fatty acid synthesis (mtFAS). It reduces trans-2-enoyl-ACP to acyl-ACP using NADPH. This pathway is essential for mitochondrial function, including lipoic acid biosynthesis and oxidative phosphorylation. Mutations in MECR cause mitochondrial enoyl-CoA reductase protein-associated neurodegeneration (MEPAS), a disorder characterized by dystonia, optic atrophy, and basal ganglia iron accumulation.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Mitochondrial enoyl-CoA reductase protein-associated neurodegeneration (MEPAS) Loss-of-function mutations impair mtFAS, leading to reduced lipoic acid synthesis, mitochondrial dysfunction, and iron accumulation in the brain. ClinVar, OMIM #617282
Dystonia-parkinsonism Disruption of mitochondrial energy metabolism in neurons due to MECR deficiency contributes to motor symptoms. OMIM, PubMed

Expression Profile

Tissue Expression
Tissue nTPM level
Brain 10.2 Medium
Liver 8.5 Medium
Heart 7.1 Medium
Skeletal Muscle 6.8 Medium
Kidney 5.3 Low
Cell Line Expression
Cell Line nTPM Notes
HEK293 12.4 High expression
SH-SY5Y 9.8 Neuronal model
HepG2 8.1 Liver cell line
K562 4.5 Low expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.737G>A (p.Arg246Gln) Missense Rare Reduced enzyme activity; associated with MEPAS
c.1A>G (p.Met1Val) Start loss Rare Loss of protein expression; pathogenic
c.835C>T (p.Arg279Trp) Missense Rare Impaired NADPH binding; pathogenic
Mutation functional classification

Loss of Function (LOF)

Most MECR mutations are loss-of-function, reducing or abolishing enoyl-CoA reductase activity, leading to mtFAS deficiency.

Gain of Function (GOF)

No gain-of-function mutations reported.

Dominant Negative (DN)

Not described; inheritance is autosomal recessive.

Gene Ontology (GO)

• GO:0006629 lipid metabolic process • GO:0005739 mitochondrion
• GO:0008691 2-enoyl-CoA reductase (NADPH) activity • GO:0006633 fatty acid biosynthetic process
• GO:0016491 oxidoreductase activity

Pathways

Mitochondrial fatty acid synthesis (mtFAS)
Lipoic acid metabolism
Fatty acid elongation in mitochondria

Protein Summary

MECR is a 373-amino acid protein localized to the mitochondrial matrix. It functions as a homodimer, using NADPH to reduce trans-2-enoyl-ACP to acyl-ACP. This step is critical for producing octanoyl-ACP, a precursor for lipoic acid synthesis. The enzyme is highly conserved across eukaryotes. Structural studies show a Rossmann fold for NADPH binding and a catalytic triad. Defects in MECR lead to mitochondrial dysfunction and neurodegeneration.

Related Products

Product name Cat.No. Species Gene ID
AMMECR1 Knockout HEK293 Cell Line EDJ-KQ6187 Human 9949 Details Get a Quote
AMMECR1L Knockout HEK293 Cell Line EDJ-KQ9870 Human 83607 Details Get a Quote
AMMECR1 Knockout A-549 Cell Line EDJ-KQ31382 Human 9949 Details Get a Quote
AMMECR1 Knockout HCT 116 Cell Line EDJ-KQ31383 Human 9949 Details Get a Quote
AMMECR1 Knockout HeLa Cell Line EDJ-KQ31384 Human 9949 Details Get a Quote
AMMECR1L Knockout A-549 Cell Line EDJ-KQ36743 Human 83607 Details Get a Quote
AMMECR1L Knockout HCT 116 Cell Line EDJ-KQ36744 Human 83607 Details Get a Quote
AMMECR1L Knockout HeLa Cell Line EDJ-KQ36745 Human 83607 Details Get a Quote
MECR Knockout HEK293T Cell Line EDC08075 Human 51102 Details Get a Quote
Displaying Records 1 To 9 Of 9 Records
Contact Us
*
*
*
*
How did you hear about us: